Objective : Embolization of cerebral arteriovenous malformations (AVMs) is commonly performed prior to surgical resection in order to reduce intraoperative bleeding and improve the safety of resection. Although most modern embolization procedures utilize permanent embolic agents, silk suture and polyvinyl alcohol (PVA) particles may offer unique advantages for preoperative devascularization. The aims of this retrospective cohort study are to describe the technical considerations and determine the outcomes for preoperative silk suture and PVA particle embolization (SPE) of AVMs.
INTRODUCTION
Treatment options for cerebral arteriovenous malformations (AVMs) have evolved rapidly over the past two decades, although the optimal management paradigm remains controversial. 35) Advances in microsurgical techniques and equipment, technologies for endovascular embolization, and stereotactic radiosurgery (SRS) have resulted in a number of safe and effective treatments, but selecting an appropriate treatment strategy remains challenging in many cases. Of the various interventional options for AVMs, surgical resection remains the gold standard.
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Preoperative embolization is a valuable neo-adjuvant treatment that has been shown to be effective in decreasing operative time, blood loss, and morbidity and mortality. 10) The majority of modern AVM embolization is performed using ethylene vinyl alcohol copolymer (Onyx; ev3 Neurovascular, Irvine, California, USA). 43) However, at our institution, we have found that more traditional embolic agents, such as silk suture and polyvinyl alcohol (PVA) particles, offer unique advantages over Onyx for preoperative devascularization of appropriately selected nidi.
The aims of this retrospective cohort study are to (1) describe our technique for silk suture and PVA particle 
MATERIALS AND METHODS

Patients selection and study design
We performed a retrospective review of all patients who underwent preoperative embolization of cerebral AVMs at the University of Virginia between January 2000 and June 2013. Inclusion criteria for the study were (1) preoperative SPE of the AVM nidus, (2) AVM surgical resection performed at our institution, and/or to prevent reflux of the silk suture and particles.
A final control angiogram was performed after the embolization procedure to assess the residual nidus.
Baseline variables and treatment outcomes
Patient variables were gender, age, clinical presentation, and medical comorbidities. AVM variables were location, venous drainage pattern, maximum nidus diameter, nidus volume, Spetzler-Martin grade, and presence of associated arterial and venous aneurysms. 48) Maximum nidus diameter was measured on pre-embolization angiography. AVMs were assumed to be ellipsoid and the volume was calculated accordingly.
The embolization variable was the embolic agent used.
Surgical variables were amount of intraoperative blood loss and duration of procedure. 
RESULTS
Study population and clinical presentation
AVM Characteristics
AVMs were supratentorial in 10 cases (91%) AVM embolization outcomes with silk suture and
PVA particles
The embolization procedural details and outcomes are summarized in Table 2 . In the 12 SPE procedures, the degree of AVM obliteration was < 25% in two cases (17%), 25-50% in one case (8%), 50-75% in eight cases (67%), and > 75% in one case (8%). The arterial pedicle was occluded with coils after SPE in seven cases (58%). Post-embolization complications consisted of ICH, with accompanying hemiparesis, in one patient (8%). There were no cases of post-embolization ischemia, based on clinical or radiologic assessments.
Post-embolization mRS was improved in one patient (8%), unchanged in 10 patients (83%), and worsened in one patient (8%).
AVM surgical outcomes
The details and outcomes of the AVM surgical procedures are summarized in at a median interval of one day (range 1 to 3 days) after the most recent SPE embolization, the median estimated intraoperative blood loss was 600 mL (range 200 to 4,500 mL), and the median operative duration was 326 minutes (range 237 to 579 minutes).
Based on postoperative angiography (Fig. 1) , complete
AVM obliteration was achieved in all cases (100%).
At the most recent clinical follow-up (median duration 2 months, range 1 to 156.5 months), the mRS score was 0 in one patient (9%), 1 in four patients (36%), 2 in two patients (18%), 3 in one patient (9%), 4 in two patients (18%), and 6 in one patient (9%).
Compared to baseline, six patients (55%) showed improvement from their mRS score, four patients (36%)
were unchanged, and one patient (9%) worsened. 31)
The interpretation of our results is limited, in part, by the study design as a retrospective, single-center cohort study. Thus, our study is subject to the selection biases of the neurointerventionalists and neu-rosurgeons at our institution. The cohort size is relatively small, which prohibits rigorous statistical analysis for predictors of favorable outcome and complications.
Without an equivalent cohort of non-embolized
AVMs or nidi embolized with other agents, we are unable to assess the comparative effectiveness of SPE. 
CONCLUSION
In our experience, preoperative AVM embolization with silk suture and PVA particles affords a reasonable risk to benefit profile. Although larger studies are necessary to define the role of these embolic agents in the overall management of AVMs, we believe they can be employed with relative technical ease and favorable clinical safety prior to surgical extirpation of nidi in appropriately selected patients.
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